226 related articles for article (PubMed ID: 22576130)
21. Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Lee KJ; Fattah KR; Lin YF; Fehrenbacher B; Schaller M; Chen BP; Chen DJ; Rodemann HP
Mol Cancer Res; 2012 Jul; 10(7):945-57. PubMed ID: 22596249
[TBL] [Abstract][Full Text] [Related]
22. Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells.
Davidson D; Coulombe Y; Martinez-Marignac VL; Amrein L; Grenier J; Hodkinson K; Masson JY; Aloyz R; Panasci L
Invest New Drugs; 2012 Jun; 30(3):1248-56. PubMed ID: 21221710
[TBL] [Abstract][Full Text] [Related]
23. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.
Calabrese CR; Almassy R; Barton S; Batey MA; Calvert AH; Canan-Koch S; Durkacz BW; Hostomsky Z; Kumpf RA; Kyle S; Li J; Maegley K; Newell DR; Notarianni E; Stratford IJ; Skalitzky D; Thomas HD; Wang LZ; Webber SE; Williams KJ; Curtin NJ
J Natl Cancer Inst; 2004 Jan; 96(1):56-67. PubMed ID: 14709739
[TBL] [Abstract][Full Text] [Related]
24. An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex.
Hammel M; Yu Y; Radhakrishnan SK; Chokshi C; Tsai MS; Matsumoto Y; Kuzdovich M; Remesh SG; Fang S; Tomkinson AE; Lees-Miller SP; Tainer JA
J Biol Chem; 2016 Dec; 291(53):26987-27006. PubMed ID: 27875301
[TBL] [Abstract][Full Text] [Related]
25. Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination.
Tavecchio M; Munck JM; Cano C; Newell DR; Curtin NJ
Cancer Chemother Pharmacol; 2012 Jan; 69(1):155-64. PubMed ID: 21630086
[TBL] [Abstract][Full Text] [Related]
26. Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks.
Mendoza-Munoz PL; Gavande NS; VanderVere-Carozza PS; Pawelczak KS; Dynlacht JR; Garrett JE; Turchi JJ
NAR Cancer; 2023 Mar; 5(1):zcad003. PubMed ID: 36755959
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models.
Zenke FT; Zimmermann A; Sirrenberg C; Dahmen H; Kirkin V; Pehl U; Grombacher T; Wilm C; Fuchss T; Amendt C; Vassilev LT; Blaukat A
Mol Cancer Ther; 2020 May; 19(5):1091-1101. PubMed ID: 32220971
[TBL] [Abstract][Full Text] [Related]
28. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
Liang K; Jin W; Knuefermann C; Schmidt M; Mills GB; Ang KK; Milas L; Fan Z
Mol Cancer Ther; 2003 Apr; 2(4):353-60. PubMed ID: 12700279
[TBL] [Abstract][Full Text] [Related]
29. A nonhomologous end-joining pathway is required for protein phosphatase 2A promotion of DNA double-strand break repair.
Wang Q; Gao F; Wang T; Flagg T; Deng X
Neoplasia; 2009 Oct; 11(10):1012-21. PubMed ID: 19794960
[TBL] [Abstract][Full Text] [Related]
30. Feedback autophagy activation as a key resistance factor of Ku-0060648 in colorectal cancer cells.
Mao M; Liu Y; Gao X
Biochem Biophys Res Commun; 2017 Sep; 490(4):1244-1249. PubMed ID: 28676397
[TBL] [Abstract][Full Text] [Related]
31. Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.
Li Y; Wang X; Yue P; Tao H; Ramalingam SS; Owonikoko TK; Deng X; Wang Y; Fu H; Khuri FR; Sun SY
J Biol Chem; 2013 May; 288(19):13215-24. PubMed ID: 23536185
[TBL] [Abstract][Full Text] [Related]
32. DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining.
Head PE; Kapoor-Vazirani P; Nagaraju GP; Zhang H; Rath SK; Luong NC; Haji-Seyed-Javadi R; Sesay F; Wang SY; Duong DM; Daddacha W; Minten EV; Song B; Danelia D; Liu X; Li S; Ortlund EA; Seyfried NT; Smalley DM; Wang Y; Deng X; Dynan WS; El-Rayes B; Davis AJ; Yu DS
Nucleic Acids Res; 2023 Aug; 51(15):7972-7987. PubMed ID: 37395399
[TBL] [Abstract][Full Text] [Related]
33. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
34. DNA-PK inhibition causes a low level of H2AX phosphorylation and homologous recombination repair in Medaka (Oryzias latipes) cells.
Urushihara Y; Kobayashi J; Matsumoto Y; Komatsu K; Oda S; Mitani H
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):131-6. PubMed ID: 23142596
[TBL] [Abstract][Full Text] [Related]
35. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
[TBL] [Abstract][Full Text] [Related]
37. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.
Lin MZ; Marzec KA; Martin JL; Baxter RC
Oncogene; 2014 Jan; 33(1):85-96. PubMed ID: 23178489
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin.
Kim SH; Um JH; Dong-Won B; Kwon BH; Kim DW; Chung BS; Kang CD
Leuk Res; 2000 Nov; 24(11):917-25. PubMed ID: 11086175
[TBL] [Abstract][Full Text] [Related]
39. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase.
Izzard RA; Jackson SP; Smith GC
Cancer Res; 1999 Jun; 59(11):2581-6. PubMed ID: 10363977
[TBL] [Abstract][Full Text] [Related]
40. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks.
Uematsu N; Weterings E; Yano K; Morotomi-Yano K; Jakob B; Taucher-Scholz G; Mari PO; van Gent DC; Chen BP; Chen DJ
J Cell Biol; 2007 Apr; 177(2):219-29. PubMed ID: 17438073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
